Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Displaying entries 101 - 125 of 6046 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass Formula ▼
Gangliosides LMSP0601BH08
  • Gal-GD1b(d18:1/26:1(17Z))
  • Galalpha1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44262235 2109.134456 C98H172N4O44
Gangliosides LMSP0601BI08
  • Fuc-GD1b(d18:1/26:1(17Z))
  • Fucalpha1-2Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44262243 2093.139541 C98H172N4O43
Gangliosides LMSP0601EA08
  • NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
  • disialyl Lea(d18:1/26:1(17Z))
44262755 2093.139541 C98H172N4O43
Gangliosides LMSP0601BQ02
  • NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44262301 2234.09411 C98H171N5O51
Gangliosides LMSP0601GB02
  • NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44263141 2202.10428 C98H171N5O49
Gangliosides LMSP0601BX07
  • GalNAc-GD1a(Neu5Ac/Neu5Gc)(d18:1/24:1(15Z))
  • GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44262362 2138.12462 C98H171N5O45
Gangliosides LMSP0601CA07
  • GalNAc-GD1a(Neu5Gc/Neu5Ac)(d18:1/24:1(15Z))
  • GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44262386 2138.12462 C98H171N5O45
Gangliosides LMSP0601BG07
  • GalNAc-GD1a(d18:1/24:1(15Z))
  • GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44262226 2122.129705 C98H171N5O44
Gangliosides LMSP0601CP06
  • GalNAcalpha1-3GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44262489 2064.16061 C97H173N5O41
Gangliosides LMSP0601CX06
  • GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44262553 2064.16061 C97H173N5O41
Gangliosides LMSP0601DQ06
  • GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44262681 2064.16061 C97H173N5O41
Gangliosides LMSP0601BR04
  • Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44262311 2113.129371 C97H172N4O45
Gangliosides LMSP0601DN04
  • NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44262655 2113.129371 C97H172N4O45
Gangliosides LMSP0601EJ04
  • NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
  • sialyl Lex(d18:1/22:0)
44262823 2113.129371 C97H172N4O45
Gangliosides LMSP0601EM04
  • NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44262847 2113.129371 C97H172N4O45
Gangliosides LMSP0601EX04
  • NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44262927 2113.129371 C97H172N4O45
Gangliosides LMSP0601FJ04
  • NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
  • VIM-II(d18:1/22:0)
44263015 2113.129371 C97H172N4O45
Gangliosides LMSP0601FM04
  • NeuAcalpha2-3Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44263039 2113.129371 C97H172N4O45
Gangliosides LMSP0601GI04
  • NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44263199 2113.129371 C97H172N4O45
Gangliosides LMSP0601DX04
  • NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3(Fucalpha1-3GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44262727 2097.134456 C97H172N4O44
Gangliosides LMSP0601EP03
  • NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44262870 2158.11445 C97H171N5O47
Gangliosides LMSP0601DR03
  • GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GlcNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44262686 2142.119535 C97H171N5O46
Gangliosides LMSP0601EY03
  • NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44262934 2142.119535 C97H171N5O46
Gangliosides LMSP0601FO03
  • NeuAcalpha2-3Galbeta1-4GlcNAcalpha1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44263054 2142.119535 C97H171N5O46
Gangliosides LMSP0601GP03
  • GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44263238 2142.119535 C97H171N5O46

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024